Aromatase Inhibitors versus levonorgestrel-realeasing intrauterine device for the treatment of moderate to severe endometriosis[INHIBIDORES DE LA AROMATASA (ANASTROZOL) ASOCIADOS A DISPOSITIVO INTRAUTERINO LIBERADOR DE LEVONORGESTREL (DIU-LNG) EN EL TRATAMIENTO DE LA ENDOMETRIOSIS MODERADA/SEVERA]

Trial Profile

Aromatase Inhibitors versus levonorgestrel-realeasing intrauterine device for the treatment of moderate to severe endometriosis[INHIBIDORES DE LA AROMATASA (ANASTROZOL) ASOCIADOS A DISPOSITIVO INTRAUTERINO LIBERADOR DE LEVONORGESTREL (DIU-LNG) EN EL TRATAMIENTO DE LA ENDOMETRIOSIS MODERADA/SEVERA]

Recruiting
Phase of Trial: Phase III

Latest Information Update: 31 Oct 2011

At a glance

  • Drugs Anastrozole (Primary) ; Levonorgestrel
  • Indications Endometriosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top